surface area
Tafalgie Therapeutics expands R&D capabilities and moves into new premises Tafalgie Therapeutics, a biopharmaceutical research company specializing in the development of treatments for relieving and preventing acute and chronic pain (inflammatory, postoperative, neuropathic) without adverse effects, is pleased to announce that its teams are today moving to a new site with dedicated research and support […]
Lire la suite